Treatment Outcomes of Esophageal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony lub podejrzewany rak przełyku (na podstawie badania radiologicznego lub gastroskopii)
- •Wiek 18 lat lub więcej
✗ Disqualifies
- •Brak możliwości wyrażenia świadomej zgody na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 22, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (6)
Tenwek Hospital
Bomet, Kenya
Moi Teaching and Referral Hospital
Eldoret, Kenya
Kamuzu Central Hospital
Lilongwe, Malawi
Muhimbili National Hospital
Dar es Salaam, Tanzania
Ocean Road Cancer Institute
Dar es Salaam, Tanzania
Kilimanjaro Christian Medical Centre
Moshi, Tanzania
Trial contact
Geoffrey Buckle, MD, MPH
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.